Telomere-related DNA damage response pathways in cancer therapy: prospective targets

Maintaining the structural integrity of genomic chromosomal DNA is an essential role of cellular life and requires two important biological mechanisms: the DNA damage response (DDR) mechanism and telomere protection mechanism at chromosome ends. Because abnormalities in telomeres and cellular DDR re...

Full description

Saved in:
Bibliographic Details
Main Authors: Liting Gu (Author), Mingdi Liu (Author), Yuning Zhang (Author), Honglan Zhou (Author), Yishu Wang (Author), Zhi-Xiang Xu (Author)
Format: Book
Published: Frontiers Media S.A., 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1a159fc4f47f4bf0bb23db8b5f6cac01
042 |a dc 
100 1 0 |a Liting Gu  |e author 
700 1 0 |a Mingdi Liu  |e author 
700 1 0 |a Yuning Zhang  |e author 
700 1 0 |a Honglan Zhou  |e author 
700 1 0 |a Yishu Wang  |e author 
700 1 0 |a Zhi-Xiang Xu  |e author 
245 0 0 |a Telomere-related DNA damage response pathways in cancer therapy: prospective targets 
260 |b Frontiers Media S.A.,   |c 2024-06-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2024.1379166 
520 |a Maintaining the structural integrity of genomic chromosomal DNA is an essential role of cellular life and requires two important biological mechanisms: the DNA damage response (DDR) mechanism and telomere protection mechanism at chromosome ends. Because abnormalities in telomeres and cellular DDR regulation are strongly associated with human aging and cancer, there is a reciprocal regulation of telomeres and cellular DDR. Moreover, several drug treatments for DDR are currently available. This paper reviews the progress in research on the interaction between telomeres and cellular DNA damage repair pathways. The research on the crosstalk between telomere damage and DDR is important for improving the efficacy of tumor treatment. However, further studies are required to confirm this hypothesis. 
546 |a EN 
690 |a alternative lengthening of telomeres 
690 |a cancer 
690 |a DNA damage response 
690 |a telomerase inhibitor 
690 |a telomere 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 15 (2024) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1379166/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/1a159fc4f47f4bf0bb23db8b5f6cac01  |z Connect to this object online.